Extensive Therapeutic Drug Monitoring of Colistin in Critically Ill Patients Reveals Undetected Risks

Extensive Therapeutic Drug Monitoring of Colistin in Critically Ill Patients Reveals Undetected Risks

(1) Background: With the rise of multi-/pan-drug resistant (MDR/PDR) pathogens, the less utilized antibiotic Colistin has made a comeback. Colistin fell out of favor due to its small therapeutic range and high potential for toxicity. Today, it is used again as a last resort substance in treating MDR...

Full description

Bibliographic Details
Main Authors:	Stefan Felix Ehrentraut, Stefan Muenster, Stefan Kreyer, Nils Ulrich Theuerkauf, Christian Bode, Folkert Steinhagen, Heidi Ehrentraut, Jens-Christian Schewe, Matthias Weber, Christian Putensen, Thomas Muders
Format:	Article
Language:	English
Published:	MDPI AG 2020-03-01
Series:	Microorganisms
Subjects:	colistin sepsis colistin methanosulfate therapeutic drug monitoring intensive care medicine renal failure polymyxin e acinetobacter baumannii carbapenem resistant
Online Access:	https://www.mdpi.com/2076-2607/8/3/415

Similar Items

In Vitro Activity of Tigecycline and Colistin against clinical isolates of Acinetobacter baumannii in Hospitals in Tehran and Bandar-Abbas, Iran
by: Shahin najar peerayeh, et al.
Published: (2014-03-01)

Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis
by: Cheng Lyu, et al.
Published: (2020-04-01)

Antimicrobial Activity of Colistin Against Contemporary (2015 – 2017) P. aeruginosa and A. baumannii Isolates From a Chinese Surveillance Program
by: Hui Zhang, et al.
Published: (2020-09-01)

New Mutations Involved in Colistin Resistance in Acinetobacter baumannii
by: Bingbing Sun, et al.
Published: (2020-04-01)

Colistin and Carbapenem-Resistant <i>Acinetobacter baumannii</i> Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling
by: Nalumon Thadtapong, et al.
Published: (2021-08-01)

Genetic Background of Carbapenem Resistant Acinetobacter baumannii in a Health Care Setting in Alexandria, Egypt
by: Amira Amine, et al.
Published: (2011-09-01)

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
by: Shi H, et al.
Published: (2019-12-01)

Synergistic Activity of Capsaicin and Colistin Against Colistin-Resistant Acinetobacter baumannii: In Vitro/Vivo Efficacy and Mode of Action
by: Tingting Guo, et al.
Published: (2021-09-01)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021-07-01)

Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii
by: Marta Carretero-Ledesma, et al.
Published: (2018-12-01)

Lipopolysaccharide-Deficient Acinetobacter baumannii Due to Colistin Resistance Is Killed by Neutrophil-Produced Lysozyme
by: Go Kamoshida, et al.
Published: (2020-04-01)

Influencing factors of successful eradication of multidrug-resistant Acinetobacter baumannii in the respiratory tract with aerosolized colistin
by: Yu-Mu Chen, et al.
Published: (2014-10-01)

In vitro activity of colistin mono- and combination therapy against colistin-resistant Acinetobacter baumannii, mechanism of resistance, and clinical outcomes of patients infected with colistin-resistant A. baumannii at a Thai university hospital
by: Lertsrisatit Y, et al.
Published: (2017-11-01)

Efficacy of colistin and rifampin combination for treatment of ventilator associated pneumonia caused by carbapenem resistant Acinetobacter baumannii: brief report
by: Masoomeh Sofian, et al.
Published: (2020-02-01)

Determination of Colistin and Tigecycline Resistance Profile of Acinetobacter Baumannii Strains from Different Clinical Samples in a Territory Hospital in Turkey
by: Merih Şimşek, et al.
Published: (2020-03-01)

Potentiation of antimicrobial activity of colistin with antibiotics of different groups against multidrug- and extensively drug-resistant strains of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa
by: Tapalskiy D.V., et al.
Published: (2020-05-01)

Detection of colistin sensitivity in clinical isolates of Acinetobacter baumannii in Iran
by: Bahareh Vakili, et al.
Published: (2014-01-01)

Colistin Dependence in Extensively Drug-Resistant <i>Acinetobacter baumannii</i> Strain Is Associated with IS<i>Ajo2</i> and IS<i>Aba13</i> Insertions and Multiple Cellular Responses
by: Sherley Chamoun, et al.
Published: (2021-01-01)

A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Critically Ill Patients: A Propensity Score-Matched Analysis
by: Wasan Katip, et al.
Published: (2020-09-01)

Colistin in Light of Current Data
by: İftihar KÖKSAL, et al.
Published: (2012-12-01)

Impact of Colistin Dosing on the Incidence of Nephrotoxicity in a Tertiary Care Hospital in Saudi Arabia
by: Reem Almutairy, et al.
Published: (2020-08-01)

In vitro activities of colistin, imipenem and ceftazidime against drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in the south of Iran
by: Yalda Malekzadegan, et al.
Published: (2019-05-01)

Enhanced antibacterial activity of Acinetobacter baumannii bacteriophage ØABP-01 endolysin (LysABP-01) in combination with colistin
by: Rapee Thummeepak, et al.
Published: (2016-09-01)

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021-07-01)

Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii
by: Bin Liu, et al.
Published: (2014-07-01)

Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
by: Rafael Ayerbe-Algaba, et al.
Published: (2018-10-01)

Survey on Genetic Diversity, Biofilm Formation, and Detection of Colistin Resistance Genes in Clinical Isolates of Acinetobacter baumannii
by: Khoshnood S, et al.
Published: (2020-05-01)

Postcraniofacial trauma multidrug resistant Acinetobacter Baumannii infection treated with intravenous colistin: A rare complication
by: Sanjay Rastogi, et al.
Published: (2013-01-01)

Colistin and tigecycline for management of external ventricular device-related ventriculitis due to multidrug-resistant Acinetobacter baumannii
by: Gentle Sunder Shrestha, et al.
Published: (2016-07-01)

Molecular characteristics of carbapenem-resistant Acinetobacter spp. from clinical infection samples and fecal survey samples in Southern China
by: Si Li, et al.
Published: (2019-10-01)

Evaluation of Synergistic Effect of Combined Treatment with Linalool and Colistin on Multidrug-ResistantAcinetobacter baumannii to Expand Candidate for Therapeutic Option
by: Ung-Jun Kim, et al.
Published: (2020-03-01)

Investigation of the Synergic Effect of the Colistin/ Sulbactam Combination in Carbapenem-Resistant Acinetobacter baumannii complex Strains with Time-Kill and Checkerboard Methods
by: İmdat KILBAŞ, et al.
Published: (2021-03-01)

Interplay between Colistin Resistance, Virulence and Fitness in Acinetobacter baumannii
by: Gabriela Jorge Da Silva, et al.
Published: (2017-11-01)

Plasmid-mediated mcr-1 in carbapenem-susceptible Escherichia coli ST156 causing a blood infection: an unnoticeable spread of colistin resistance in Brazil?
by: Flavia Rossi, et al.

Bacteremia by colistin-resistant Acinetobacter baumannii isolate: a case report
by: Julio Cesar Garcia Casallas, et al.
Published: (2019-05-01)

Clinical Efficacy and Nephrotoxicity of Colistin Alone versus Colistin Plus Vancomycin in Critically Ill Patients Infected with Carbapenem-Resistant <i>Acinetobacter baumannii</i>: A Propensity Score-Matched Analysis
by: Wasan Katip, et al.
Published: (2021-01-01)

The effectiveness and nephrotoxicity of loading dose colistin combined with or without meropenem for the treatment of carbapenem-resistant A. baumannii
by: Wasan Katip, et al.
Published: (2020-08-01)

Molecular evaluation of colistin-resistant gene expression changes in Acinetobacter baumannii with real-time polymerase chain reaction
by: Sepahvand S, et al.
Published: (2017-11-01)

Colistin Resistance in Enterobacterales Strains – A Current View
by: ELŻBIETA M. STEFANIUK, et al.
Published: (2019-12-01)

Development of indirect competitive enzyme-linked immunoassay of colistin for milk and egg analysis
by: Inna A. Galvidis, et al.
Published: (2020-01-01)